can holdover for 3 days as compared to the heavy series for 13 days . It just requires itself to recharge 2.5 hours of electricity every day .
We hear stories on spoiling of vaccines due to heat conditions in Indian rural terrains . Will these products be of help ?
When the vaccines cross the temperature over 8 degrees Celsius or below 2 degrees Celsius , it is as good as water with zero efficacy . The important factors to retain the impact of vaccines are their efficacy and second is the right storage . That is what we are trying to do through with our product .
All products continue to guarantee never to freeze vaccines because of the patented technology , limit temperature variation within cabinet to less than 1 degree Celsius , have a built in intelligent temperature control and energy management . In terms of product offering , this portfolio is the best in market today .
Are you planning for any collaboration with government bodies or pharma companies ?
The recent conference at Delhi has been to bring visibility to the technology and educate the stakeholders about the issues being faced in the medical refrigeration . We have been informing the government agencies about this product and the benefits coming with it .
What do you make of ‘ Make in India campaign and does this product fit here ?
This is the only medical refrigerator in this category that is manufactured in India . No other brand does that here . It is getting manufactured at our Vikhroli unit in Mumbai in parallel with one in Pune . While currently the number is 10,000 units , we are planning to increase the capacity of manufacturing facility to 30,000 units over next 2 years .
“
There are many global players in the Indian market yet their products can ’ t guarantee you the precise temperature in wake of fluctuations . Vaccines get spoiled and emphasis is on the temperature side .
Coming to the business aspects , what are the market trends including competition etc ?
The market size of the medical refrigerators for vaccines is roughly Rs 500 crore in last one year . It is expected to grow exponentially .
There are many global players in the Indian market yet their products can ’ t guarantee you the precise temperature in wake of fluctuations . Vaccines get spoiled and emphasis is on the temperature side .
Godrej is generally known for the household refrigerators . But now as you have ventured into medical domain , what are your detailed plans ?
Since we have now moved into medical refrigeration and especially vaccines storage , we are also planning to venture into blood banking as well . Blood storage also requires precise temperature . This technology is also prefect for blood banks . We will come up with wide portfolio for blood banks . We will go to the other areas of medical sciences where refrigeration is required to safeguard products .
Is the product being used globally too ? What is the cost ?
Sure Chill ’ s technology is being used in 38 nations and we too will be supplying the latest product there .
The price of entire range varies from Rs 1.5 lakh to Rs 5 Lakh whereas the Lite series price range is between Rs 70,000 to Rs 75,000 The re-engineering and for bringing out right efficiencies , there have been efforts by our engineers . Therefore , the price optimization is complete and we cannot go beyond this decrease . I would say this is highly affordable in this category .
How has been the response from the clients ?
Wherever we have installed the machine so far , we have received the good response . For example , in the West Bengal where we installed at 38 locations , the response is overwhelming . People are happy about the display board that gives them the exact temperature inside the refrigerator . Over that the maintenance is zero and so far not a single complaint has been received about any vaccine lot getting spoiled or anything like that .
What is your expectation is terms of revenue and future outlook ?
There is a huge potential . We hope to generate Rs 200 crore revenue from medical refrigerator portfolio by 2020 .
I believe that we are not looking at the right technologies that could bring down wastage considerably . We must look out and use innovation to bring down the cost and improve efficacy .
BIOVOICENEWS . COM 39